Even though gemcitabine is delivered into the cancer cells, gemcitabine is quickly metabolized to non-toxic metabolites like cytosine by thymidine phosphorylase and other enzymes, which would reduce the antiproliferative activity in pancreatic cancer cells [69,70,71]. Here, TYMP is linked to pancreatic neoplasm.